Country: New Zealand
Lingwa: Ingliż
Sors: Ministry for Primary Industries
feline calici virus (attenuated); feline panleucopenia virus (attenuated); feline rhinotracheitis virus (attenuated)
Schering-Plough Animal Health Limited
feline rhinotracheitis virus (attenuated), feline panleucopenia virus (attenuated), feline calici virus (attenuated)
feline calici virus (attenuated) 0 vaccine; feline panleucopenia virus (attenuated) 0 vaccine; feline rhinotracheitis virus (attenuated) 0 vaccine
Vaccine
ACVM Registered
2008-09-22
NOBIVAC TRICAT TRIO 5 ds and 25 ds – Inlay and Labels A010164 Page 1 of 6 NOBIVAC TRICAT TRIO 02-Apr-2021 Inlay – Front Cover RESTRICTED VETERINARY MEDICINE KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY NOBIVAC ® TRICAT TRIO 5 [25] vials containing combined live attenuated freeze-dried feline viral herpes virus, feline calicivirus and feline panleucopaenia virus vaccine. 5 [25] vials of sterile diluent for reconstitution of freeze-dried Nobivac feline vaccines. 5 X 1 DOSE [25 X 1 DOSE] MSD AH logo Inlay – Inside Panels RESTRICTED VETERINARY MEDICINE KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY NOBIVAC ® TRICAT TRIO Live attenuated vaccine for cats. A live freeze-dried vaccine, containing: - Live attenuated feline calicivirus (strain F9) - Live attenuated feline herpes virus type 1 (rhinotracheitis) (strain G2620A) - Live attenuated feline panleucopaenia virus (strain MW-1) It is presented as a freeze-dried pellet; each pack contains 5 or 25 single dose vials. Pack also contains 5 or 25 corresponding 1 mL vials of diluent for reconstitution prior to injection. INDICATION For active immunisation of cats from the age of 8-9 weeks onwards to: - reduce clinical signs caused by an infection with feline calicivirus (FCV) and feline herpes virus type 1 (FHV) - to reduce replication of feline calicivirus (FCV) - and to prevent clinical signs, leucopenia and shedding caused by infection with feline panleucopaenia virus (FPLV) The onset of immunity is 4 weeks for FCV and FHV, and 3 weeks for FPLV following first vaccination. NOBIVAC TRICAT TRIO 5 ds and 25 ds – Inlay and Labels A010164 Page 2 of 6 NOBIVAC TRICAT TRIO 02-Apr-2021 The duration of immunity is 3 years for the FCV, FHV and FPLV components, as confirmed by challenge study. DOSAGE AND ADMINISTRATION INITIAL PROGRAMME Two doses injected subcutaneously, at an interval of 3-4 weeks are required. The first vaccination is given from the age of 8-9 weeks and the second vaccination from the age of 12 weeks. If earlier vaccination is desirab Aqra d-dokument sħiħ